What's next for GLP-1s?

Now that GLP-1 drugs have revolutionized how millions of Americans treat obesity and Type 2 diabetes, scientists are exploring the benefits of using the drugs for a host of other chronic diseases—many with few treatment ...

Interoperable data systems can improve cancer care

Cancer centers today are facing growing pressure from stakeholders across the cancer care and research community to meet data-driven expectations. Yet many centers continue to rely on fragmented, siloed data systems that ...

page 6 from 40